Yaming Li

机构：Shanghai Medical College of Fudan University, Shandong University, Chinese Academy of Medical Sciences & Peking Union Medical College, First Hospital of China Medical University, Beijing Drainage Group (China), Qilu Hospital of Shandong University, China Medical University · ORCID：0000-0001-5627-229X

发表论文 105 篇 · 总被引 5958 次 · h-index 35

代表论文

• Exosomal circSIPA1L3-mediated intercellular communication contributes to glucose metabolic reprogramming and progression of triple negative breast cancer (2024 · Molecular Cancer · 被引 49)
• China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition) (2025 · Liver Cancer · 被引 42)
• CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K/AKT/mTOR activation (2024 · Molecular Cancer · 被引 41)
• CircCFL1 Promotes TNBC Stemness and Immunoescape via Deacetylation‐Mediated c‐Myc Deubiquitylation to Facilitate Mutant TP53 Transcription (2024 · Advanced Science · 被引 32)
• COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk (2024 · Oncogene · 被引 27)
• Trim21-mediated CCT2 ubiquitination suppresses malignant progression and promotes CD4+T cell activation in breast cancer (2024 · Cell Death and Disease · 被引 23)